Potential Treatment For Parkinson’s Disease With New Neurotrophic Factor

Parkinson’s disease is a degenerative brain disease characterized by the loss of dopamine neurons in the midbrain-area called Substantia Nigra. The research group led by professor Mart Saarma, Director of the Institute of Biotechnology, University of Helsinki, has discovered a novel neurotrophic factor CDNF (Conserved Dopamine Neurotrophic Factor). [click link for full article]

More: continued here

Filed under: Parkinson's Disease on July 10th, 2007